# A Study of LY2140023 in Healthy Participants

> **NCT01659177** · PHASE1 · WITHDRAWN · sponsor: **Denovo Biopharma LLC**

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** LY2140023

## Key facts

- **NCT ID:** NCT01659177
- **Lead sponsor:** Denovo Biopharma LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-08
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The decision to stop the trial was based on efficacy results in the overall schizophrenia patient population.
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01659177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01659177, "A Study of LY2140023 in Healthy Participants". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01659177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*